PYC Therapeutics Limited (PYC.AX)
AUD 1.41
(-6.0%)
AUD 1.41
(-6.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 22.05 Million | 15.8 Million | 16.04 Million | 3.07 Million | 2.39 Million | - |
| Cost of Revenue | - | 882.04 Thousand | 839.5 Thousand | 622.36 Thousand | 547.11 Thousand | 130.55 Thousand |
| Gross Profit | 22.05 Million | 14.92 Million | 15.2 Million | 2.45 Million | 1.84 Million | -130.55 Thousand |
| Operating Expenses | 60.91 Million | 38.28 Million | 29.36 Million | 21.21 Million | 9.15 Million | 6.97 Million |
| Selling, General and Administrative Expenses | 4.5 Million | 3.13 Million | 5.33 Million | 7.2 Million | 3.27 Million | 2.45 Million |
| Research and Development Expenses | 56.4 Million | 35.14 Million | 24.03 Million | 14 Million | 5.87 Million | 4.51 Million |
| Other Expenses | - | 15.75 Million | 15.92 Million | 3.13 Million | 62.5 Thousand | 250.00 |
| Cost and Expenses | 60.91 Million | 39.16 Million | 30.2 Million | 21.83 Million | 9.7 Million | 7.1 Million |
| Operating Income | -38.85 Million | -39.16 Million | -30.2 Million | -21.83 Million | -9.7 Million | -7.1 Million |
| Interest Expense | 49.2 Thousand | 27.28 Thousand | 32.59 Thousand | 38.82 Thousand | 42.92 Thousand | - |
| Income Tax Expense | -17.55 Million | -15.8 Million | -15.97 Million | -3.07 Million | -2.39 Million | -2.9 Million |
| Earnings before Tax | -55.66 Million | -39.16 Million | -30.26 Million | -21.7 Million | -9.47 Million | -6.98 Million |
| Net Income | -37.72 Million | -22.78 Million | -13.86 Million | -17.76 Million | -6.82 Million | -4.07 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.00 | -0.01 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.00 | -0.01 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 3.92 Billion | 3.24 Billion | 3.21 Billion | 3.12 Billion | 2.79 Billion | 2.79 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.93 Billion | 3.24 Billion | 3.21 Billion | 3.12 Billion | 2.79 Billion | 2.79 Billion |
| Gross Margin | 1.00 | 0.94 | 0.95 | 0.80 | 0.77 | - |
| EBIT Margin | -1.73 | -2.42 | -1.83 | -6.90 | -3.82 | - |
| Profit Margin | -1.71 | -1.44 | -0.86 | -5.78 | -2.85 | - |
| EBITDA | -38.11 Million | -38.25 Million | -29.39 Million | -21.03 Million | -8.88 Million | -6.97 Million |
| Earnings Before Tax Margin | -1.76 | -2.48 | -1.88 | -7.10 | -4.05 | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 13.15 Million | 8.9 Million | 12.33 Million | 15.8 Million | 3.47 Million |
| Cost of Revenue | 1.06 Million | 731.34 Thousand | 336.42 Thousand | 93.5 Thousand | 882.04 Thousand | 457.71 Thousand |
| Gross Profit | -1.06 Million | 12.42 Million | 8.57 Million | 12.24 Million | 14.92 Million | 3.01 Million |
| Operating Expenses | 59.35 Million | 36.57 Million | 24 Million | 18.72 Million | 38.28 Million | 19.95 Million |
| Selling, General and Administrative Expenses | - | 2.01 Million | 2.15 Million | 1.52 Million | - | 2.01 Million |
| Research and Development Expenses | - | 34.56 Million | 21.84 Million | 17.19 Million | - | 17.94 Million |
| Other Expenses | - | - | - | - | 15.75 Million | - |
| Cost and Expenses | 60.42 Million | 36.57 Million | 24.34 Million | 18.82 Million | 39.16 Million | 20.41 Million |
| Operating Income | -60.42 Million | -23.42 Million | -24.34 Million | -18.82 Million | -39.16 Million | -20.41 Million |
| Interest Expense | 49.2 Thousand | 12.55 Thousand | 36.65 Thousand | 14.93 Thousand | 27.28 Thousand | 12.35 Thousand |
| Income Tax Expense | -17.55 Million | -8.65 Million | -8.9 Million | -12.33 Million | -15.8 Million | -3.47 Million |
| Earnings before Tax | -55.66 Million | -22.85 Million | -24.16 Million | -18.74 Million | -39.16 Million | -20.41 Million |
| Net Income | -37.72 Million | -22.63 Million | -15.09 Million | -6.55 Million | -22.78 Million | -16.23 Million |
| Earnings Per Share Basic | - | -0.01 | -0.00 | -0.00 | - | -0.01 |
| Earnings Per Share Diluted | - | -0.01 | -0.00 | -0.00 | - | -0.01 |
| Weighted Average Shares Outstanding | 3.93 Billion | 4.08 Billion | 3.77 Billion | 3.32 Billion | 3.24 Billion | 3.21 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.93 Billion | 4.09 Billion | 3.77 Billion | 3.32 Billion | 3.24 Billion | 3.21 Billion |
| Gross Margin | - | 0.94 | 0.96 | 0.99 | 0.94 | 0.87 |
| EBIT Margin | - | -1.75 | -2.70 | -1.52 | - | -5.75 |
| Profit Margin | - | -1.72 | -1.69 | -0.53 | -1.44 | -4.68 |
| EBITDA | - | -23.01 Million | -24 Million | -18.72 Million | - | -19.95 Million |
| Earnings Before Tax Margin | - | -1.78 | -2.73 | -1.53 | -2.48 | -5.88 |
0403
PPLFY
MET-PA
0152
C09
JIN